193. Preclinical and Clinical Data with a Fully Serotype 3 Oncolytic Adenovirus Ad3-hTERT-E1A in the Treatment of Advanced Solid Tumors

Molecular Therapy ◽

10.1016/s1525-0016(16)37634-1 ◽

2010 ◽

Vol 18 ◽

pp. S74 ◽

Keyword(s):

Solid Tumors ◽

Clinical Data ◽

Oncolytic Adenovirus ◽

Advanced Solid Tumors

Download Full-text

Selected Combination Therapy with Sorafenib: A Review of Clinical Data and Perspectives in Advanced Solid Tumors

The Oncologist ◽

10.1634/theoncologist.2007-0233 ◽

2008 ◽

Vol 13 (8) ◽

pp. 845-858 ◽

Author(s):

Lissandra Dal Lago ◽

Véronique D'Hondt ◽

Ahmad Awada

Keyword(s):

Combination Therapy ◽

Solid Tumors ◽

Clinical Data ◽

Advanced Solid Tumors

Download Full-text

688. A Phase I Study of Intratumoral (IT) Injection of the Replication-Competent Oncolytic Adenovirus Telomelysin (OBP-301) in Patients with Advanced Solid Tumors

Molecular Therapy ◽

10.1016/s1525-0016(16)40091-2 ◽

2008 ◽

Vol 16 ◽

pp. S257

Keyword(s):

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Oncolytic Adenovirus ◽

Advanced Solid Tumors

Download Full-text

Abstract CT024: Early safety from an open label Phase I study to evaluate the safety and efficacy of a telomerase-specific oncolytic adenovirus (OBP-301) with pembrolizumab in patients with advanced solid tumors. (EPOC1505)

10.1158/1538-7445.am2019-ct024 ◽

2019 ◽

Author(s):

Takashi Kojima ◽

Toshiyoshi Fujiwara ◽

Yasuhiro Shirakawa ◽

Keisuke Hori ◽

Hiromi Ono ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Oncolytic Adenovirus ◽

Advanced Solid Tumors ◽

Safety And Efficacy ◽

Open Label Phase

Download Full-text

Abstract CT024: Early safety from an open label Phase I study to evaluate the safety and efficacy of a telomerase-specific oncolytic adenovirus (OBP-301) with pembrolizumab in patients with advanced solid tumors. (EPOC1505)

10.1158/1538-7445.sabcs18-ct024 ◽

2019 ◽

Author(s):

Takashi Kojima ◽

Toshiyoshi Fujiwara ◽

Yasuhiro Shirakawa ◽

Keisuke Hori ◽

Hiromi Ono ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Oncolytic Adenovirus ◽

Advanced Solid Tumors ◽

Safety And Efficacy ◽

Open Label Phase

Download Full-text

Featured Clinical Trial: Immunotoxin Therapy for Advanced Solid Tumors

PsycEXTRA Dataset ◽

10.1037/e305952005-008 ◽

2004 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Solid Tumors ◽

Advanced Solid Tumors

Download Full-text

Featured Clinical Trial: Targeted Combination Therapy for Advanced Solid Tumors

PsycEXTRA Dataset ◽

10.1037/e413342005-008 ◽

2005 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Combination Therapy ◽

Solid Tumors ◽

Advanced Solid Tumors

Download Full-text

Phase 1 First Time in Humans (FTIH), Open Label Study of GSK3745417 Administered to Subjects With Advanced Solid Tumors

Case Medical Research ◽

10.31525/ct1-nct03843359 ◽

2000 ◽

Author(s):

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Open Label Study ◽

Label Study ◽

Download Full-text

AMG 404 in Patients With Advanced Solid Tumors.

Case Medical Research ◽

10.31525/ct1-nct03853109 ◽

2019 ◽

Author(s):

Keyword(s):

Solid Tumors ◽

Advanced Solid Tumors

Download Full-text

Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

Case Medical Research ◽

10.31525/ct1-nct03919292 ◽

2019 ◽

Author(s):

Keyword(s):

Solid Tumors ◽

Advanced Solid Tumors ◽

Expansion Cohort

Download Full-text

Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Local Advanced or Metastatic, HER2 Positive Breast Cancer.

Case Medical Research ◽

10.31525/ct1-nct03944499 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Solid Tumors ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Her2 Positive ◽

Phase 1 Study ◽

Her2 Positive Breast Cancer ◽

Local Advanced ◽

Positive Breast Cancer

Download Full-text